
Cancer Screening & Genetics in Coral Springs, FL
Tests Available:
Galleri/ Myriad Genetics
Turnaround:
Results in 2–3 weeks
Downtime:
None
Table of Contents
The most powerful weapon against cancer is finding it before it causes symptoms — when treatment is most effective, least invasive, and most likely to be curative.
At the practice of Leila C. Morris, M.D. in Coral Springs, FL, advanced cancer screening and hereditary cancer genetics testing are available in primary care — giving patients access to the most innovative early detection tools without a specialist referral.
The foundational principle of cancer screening is straightforward: most cancers are far more survivable when detected early. The five-year survival rate for colorectal cancer detected at stage I exceeds 90 percent; detected at stage IV, it falls below 15 percent.
Dr. Morris offers both of these advanced testing modalities as part of a comprehensive cancer prevention strategy. Dr. Morris has been serving patients in Coral Springs since 2002, welcoming patients from Coral Springs, Parkland, Coconut Creek, Margate, and throughout Broward County.
Multi-cancer early detection (MCED) tests analyze circulating cell-free DNA (cfDNA) in the bloodstream — fragments of DNA shed by cells throughout the body,
including cancer cells — for methylation patterns that are characteristic of cancer tissue. When cancer is present, even at an early stage, the methylation signature of cancer-derived cfDNA differs measurably from normal cfDNA, allowing the test to detect a cancer signal and in many cases identify the tissue of origin.
Hereditary cancer genetics testing analyzes a patient's germline DNA — the inherited genetic material present in every cell — for pathogenic variants in genes that confer substantially elevated lifetime cancer risk. The most recognized examples are BRCA1 and BRCA2, mutations in which increase lifetime breast cancer risk to 50 to 70 percent and ovarian cancer risk to 15 to 45 percent.

Tests We Offer
Galleri Multi-Cancer Early Detection Test
The Galleri test is a simple blood draw that screens for signals from over 50 types of cancer simultaneously — including pancreatic, ovarian, liver, esophageal, and many other cancers that currently have no standard early detection screening.
Myriad Genetics — Hereditary Cancer Risk Assessment
Myriad genetics hereditary cancer panels analyze a patient's germline DNA for inherited variants in the genes most strongly associated with hereditary cancer syndromes.
Standard Guideline-Based Cancer Screenings
These screenings remain the clinical standard of care and form the foundation of cancer prevention on which advanced testing is layered.
Personalized Cancer Risk Assessment
This assessment goes beyond simply ordering available tests — it applies clinical judgment about which tests are most likely to provide actionable information for each individual patient's specific risk profile.

Benefits of Advanced Cancer Screening in Primary Care
A physician who takes the time to actually know you — not just your chart.
At the practice of Dr. Leila C. Morris, M.D., Galleri and Myriad genetics testing are available as primary care services — ordered by the physician who knows your family history, your prior cancer screenings, your metabolic profile, and your personal health goals.
Board-Certified Medical Expertise
Customized Pain & Rehab Plans
Whole-Person, Functional Medicine Approach
Medical Wellness + Integrative Options
Evidence-Informed Therapies
Patient-Focused, Relationship-Based Care
Comparing Cancer Screening and Genetics Options
Galleri and Myriad genetics testing serve different but complementary purposes in cancer prevention.
Understanding what each test does — and does not — detect helps patients and physicians select the most appropriate screening strategy for each individual situation.
| Test | Key Feature | Ideal Use | Best For |
|---|---|---|---|
| Galleri Multi-Cancer Early Detection | Active cancer signal from 50+ cancer types simultaneously | Blood draw analyzes cell-free DNA methylation patterns for cancer-derived signals and predicts tissue of origin | Adults 50+ seeking comprehensive annual cancer surveillance beyond standard screenings |
| Myriad Genetics — myRisk Hereditary Cancer Panel | Inherited germline mutations in 35 cancer-predisposing genes | Saliva or blood sample analyzed for pathogenic variants in genes associated with hereditary cancer syndromes | Patients with personal or family history of cancer, or those wanting to know their inherited cancer risk before cancer develops |
| Standard Guideline Screenings (Colonoscopy, Mammogram, etc.) | Specific organ cancers per established screening protocols | Age- and risk-based protocols for colorectal, breast, cervical, lung, and other cancers | All adults — the clinical foundation of cancer prevention that advanced testing complements |
Scroll for more info

You may be an ideal candidate if you:
- Are age 50 or older and want an annual multi-cancer early detection screen that covers cancer types not addressed by standard screenings — particularly pancreatic, ovarian, liver, and esophageal cancers
- Have a personal history of cancer and want to monitor for recurrence or a second primary cancer with the most comprehensive detection tool currently available
- Have a significant family history of cancer — particularly early-onset cancers, multiple relatives with the same cancer type, or cancers in unexpected sites (e.g., male breast cancer) — that suggests a possible hereditary syndrome
- Are a woman with Ashkenazi Jewish heritage, which is associated with a substantially elevated BRCA1 and BRCA2 variant prevalence
- Have a known family member who tested positive for a hereditary cancer gene variant and want to determine whether you have inherited the same mutation
- Are interested in making fully informed decisions about enhanced surveillance, risk-reducing interventions, or family planning based on a complete understanding of your personal cancer risk
The Galleri test is a screening tool, not a diagnostic test — a positive result (cancer signal detected) does not confirm a cancer diagnosis and requires clinical follow-up and evaluation to determine whether cancer is present.
TREATMENT
OVERVIEW

Cancer Risk Consultation
Your cancer screening visit begins with a structured cancer risk assessment — reviewing your personal cancer history, family cancer history across first- and second-degree relatives, relevant environmental and lifestyle exposures, and current standard screening status.
Test Collection
The Galleri test requires a blood draw performed in-office, identical to a routine venipuncture for laboratory testing. The Myriad genetics panel is performed from a saliva sample collected in-office using a simple collection kit, or from a blood draw. Both samples are shipped to the respective testing laboratory, and results are typically returned within two to three weeks.
Results Review
Dr. Morris personally reviews all cancer screening and genetics results and schedules a dedicated appointment to discuss findings with the patient. Results are never communicated by a letter or portal message without a physician-guided discussion.
Follow-Up and Ongoing Surveillance
For patients with actionable findings, Dr. Morris coordinates the appropriate specialist referrals — oncology, surgical oncology, breast surgery, gastroenterology, or gynecology oncology as appropriate — and ensures that the enhanced surveillance or preventive interventions indicated by the finding are initiated and maintained.
Cost and Insurance Coverage
The Galleri test is currently self-pay for most patients, as insurance coverage for multi-cancer early detection tests is evolving and not yet widely available. The self-pay price is provided transparently at the time of ordering.
Related Treatments
Advanced cancer screening is most impactful when integrated into a comprehensive preventive care program. The following services are natural complements to cancer screening and genetics testing.
FAQ
Ready to Know More About Your Cancer Risk — Before Cancer Has the Chance to Develop?
Contact Dr. Leila Morris's practice today to schedule your cancer screening and genetics consultation. Dr. Morris welcomes patients from Coral Springs, Parkland, Coconut Creek, Margate, Tamarac, and throughout Broward County. The Galleri test and Myriad genetics panel are available right here in Coral Springs.
